Hospitals report these codes with terse, inconsistent chargemaster text. This plain-English title was written by an AI model from that text and has not been reviewed by a person, so it can be wrong. The prices on this page come straight from hospital filings and do not depend on it.
Original text from hospital filings
BREXUCABTAGENE AUTOLEUCEL; UP TO 200 MILLION AUTOLOGOUS ANTI-CD19 CAR POSITIVE VIABLE T CELLS; INCLUDING LEUKAPHERESIS AND DOSE PREPARATION PROCEDURES; PER THERAPEUTIC DOSE
Morgantown, WV
See all hospitals reporting HCPCS Q2053 →Price type
West Virginia University Hospitals, Inc.’s median price of $538.2k is 4% above the median hospital's median price ($519.7k), higher than 54% of the 1,142 hospitals reporting HCPCS Q2053. The highlighted bar is where this hospital falls; shaded is the middle 50% of hospitals.
Last updated: Jul 10, 2026
See CAR T-cell therapy product, per dose pricing across every hospital in the network reporting it, or ask Claude or any MCP client directly — see how to connect.